Recent Filing Shows That Rep. Josh Gottheimer Sold Over $54K Worth of Merck & Co Stock

Records from February 10, 2025 indicate that Representative Josh Gottheimer of New Jersey made a sale of Merck & Co MRK, valued between $54,040 and $635,000, with the transaction dated February 10, 2025 and filed in February.

As of now, Merck & Co shares are trading down 0.38% at $86.08.

Want to keep up with Josh Gottheimer and other congressional members' stock activities? Check out our government trades tool for real-time updates!

Why Congressional Transactions Matter

A congressional transaction is when any representative or senator either buys or sells an individual stock.

Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.

In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.

Why Congressional Transactions Matter

Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.

When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.

A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.

This article was generated by Benzinga's automated content engine and reviewed by an editor.